These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12166941)

  • 21. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
    Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
    Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of a series of dithiocarbamates as new cholinesterase inhibitors.
    Altıntop MD; Gurkan-Alp AS; Ozkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2013 Aug; 346(8):571-6. PubMed ID: 23881696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and biological evaluation of benzofuran appended benzothiazepine derivatives as inhibitors of butyrylcholinesterase and antimicrobial agents.
    Mostofi M; Mohammadi Ziarani G; Lashgari N
    Bioorg Med Chem; 2018 Jul; 26(12):3076-3095. PubMed ID: 29866481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine.
    Yu Q; Greig NH; Holloway HW; Brossi A
    J Med Chem; 1998 Jun; 41(13):2371-9. PubMed ID: 9632370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of new donepezil analogues and investigation of their effects on cholinesterase enzymes.
    Sağlık BN; Ilgın S; Özkay Y
    Eur J Med Chem; 2016 Nov; 124():1026-1040. PubMed ID: 27783974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triterpene-Based Carboxamides Act as Good Inhibitors of Butyrylcholinesterase.
    Loesche A; Kahnt M; Serbian I; Brandt W; Csuk R
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30866589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New selective acetylcholinesterase inhibitors designed from natural piperidine alkaloids.
    Viegas C; Bolzani VS; Pimentel LS; Castro NG; Cabral RF; Costa RS; Floyd C; Rocha MS; Young MC; Barreiro EJ; Fraga CA
    Bioorg Med Chem; 2005 Jul; 13(13):4184-90. PubMed ID: 15878668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine.
    Luo W; Yu QS; Kulkarni SS; Parrish DA; Holloway HW; Tweedie D; Shafferman A; Lahiri DK; Brossi A; Greig NH
    J Med Chem; 2006 Apr; 49(7):2174-85. PubMed ID: 16570913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of potent carbonic anhydrase, acetylcholinesterase, and butyrylcholinesterase enzymes inhibitors: The new amides and thiazolidine-4-ones synthesized on an acetophenone base.
    Taslimi P; Osmanova S; Gulçin İ; Sardarova S; Farzaliyev V; Sujayev A; Kaya R; Koc F; Beydemir S; Alwasel SH; Kufrevioglu OI
    J Biochem Mol Toxicol; 2017 Sep; 31(9):. PubMed ID: 28544359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
    Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
    Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
    Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo metabolism and inhibitory activities of vasicine, a potent acetylcholinesterase and butyrylcholinesterase inhibitor.
    Liu W; Shi X; Yang Y; Cheng X; Liu Q; Han H; Yang B; He C; Wang Y; Jiang B; Wang Z; Wang C
    PLoS One; 2015; 10(4):e0122366. PubMed ID: 25849329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and biological evaluation of ambenonium derivatives as AChE inhibitors.
    Bolognesi ML; Cavalli A; Andrisano V; Bartolini M; Banzi R; Antonello A; Rosini M; Melchiorre C
    Farmaco; 2003 Sep; 58(9):917-28. PubMed ID: 13679187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
    Camps P; Formosa X; Galdeano C; Gómez T; Muñoz-Torrero D; Scarpellini M; Viayna E; Badia A; Clos MV; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Estelrich J; Lizondo M; Bidon-Chanal A; Luque FJ
    J Med Chem; 2008 Jun; 51(12):3588-98. PubMed ID: 18517184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, Synthesis and Investigation of New Diphenyl Substituted Pyridazinone Derivatives as Both Cholinesterase and Aβ-Aggregation Inhibitors.
    Kilic B; Erdogan M; Gulcan HO; Aksakal F; Oruklu N; Bagriacik EU; Dogruer DS
    Med Chem; 2019; 15(1):59-76. PubMed ID: 29792155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.
    Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Tsumura Y; Akaike A; Niidome T; Takahashi T; Sugimoto H
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1721-3. PubMed ID: 20137941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of new cyclic thioureas and evaluation of their metal-chelating activity, acetylcholinesterase, butyrylcholinesterase, and carbonic anhydrase inhibition profiles.
    Taslimi P; Sujayev A; Garibov E; Nazarov N; Huyut Z; Alwasel SH; Gulçin İ
    J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28117934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.
    Vitorović-Todorović MD; Juranić IO; Mandić LM; Drakulić BJ
    Bioorg Med Chem; 2010 Feb; 18(3):1181-93. PubMed ID: 20061157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, structure-activity relationship and molecular docking studies of 3-O-flavonol glycosides as cholinesterase inhibitors.
    Mughal EU; Javid A; Sadiq A; Murtaza S; Zafar MN; Khan BA; Sumrra SH; Tahir MN; Kanwal ; Khan KM
    Bioorg Med Chem; 2018 Jul; 26(12):3696-3706. PubMed ID: 29886083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
    Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
    Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.